Herbal drugs are used for the treatment of diseases and disorders with its less side effects, easy availability and low cost. Several bioactive compounds have been isolated from medicinal plants such as Ficus benghelensis, Ficus racemosa, Ficus religiosa, Thespesia populena and Ficus lacur bouch were taken for screening. This study aimed to evaluate molecular interactions of selected diabetes mellitus (DM) targets with bioactive compounds isolated from Ficus benghelensis, Ficus racemosa, Ficus religiosa, Thespesia populena and Ficus lacur bouch. In this article, screening of the best substances as bioactive compounds is achieved by molecular docking analysis with 3 best selected DM target proteins i.e., aldose reductase (AR), Insulin Receptor (IR) and Mono-ADP ribosyltransferase-sirtuin-6 (SIRT6). In this analysis six potential bioactive compounds (gossypetin, herbacetin, kaempferol, leucoperalgonidin, leucodelphinidin and sorbifolin) were successfully identified on the basis of binding energy (>8.0 kcal/mol) and dissociation constant using YASARA. Out of six compounds, herbacetin and sorbifolin were observed as most suitable ligands for management of diabetes mellitus.
Background:
Incidence of Diabetes Mellitus (DM) is increasing every day among every population of the world. Conferring to a report by International Diabetes Federation (2011), there are 366 million people presently suffering from DM and it would up surge to 552 million till 2030. In 2000, the pervasiveness of Type 2 Diabetes Mellitus worldwide among adults was projected to be approximately 171 million [1] whereas in 2015 this number raised up to around 415 million [2] . Diabetes Mellitus is a cluster of metabolic disorder, an illness of hyperglycemia in which person grieves from disorders like failure of pancreas to produce insulin or insensitivity of cells towards insulin (insulin resistance). Diabetes Mellitus (DM) was previously called as "Non-insulin dependent diabetes mellitus" (NIDDM) [3] . Principal symptoms of DM are polyuria (recurrent urination), polydipsia (augmented thirst) and polyphagia (amplified hunger). Common explanations of Type 2 DM are lifestyle changes, obesity (defined as body mass index greater than 30), absence of physical activity, extreme body weight, deprived diet and anxiety [4] . There are numerous synthetic drugs available such as meglitinides, biguanides, sulfonylureas, thiazolidinediones, α-glucosidase inhibitors, dipeptidyl peptidase-IV inhibitors for treatment of DM [5, 34] . Today, researchers emphases primarily on finding of effective, low side effect and innocent therapeutic drugs to treat of DM [6] . Medicinal plants contain chemical groups (e.g., Phenolic acids, Flavonoids, Triterpenoids, Alkaloids and Carbohydrates) that hold strong antidiabetic properties, which can normalize blood glucose level. In traditional medicine, numerous medicinal plants were used such as Ficus benghalensis (Banyana), Ficus religiosa (Peepal), Ficus racemosa (Gular), Thespesia populnea, (Paras peepal) and Ficus lacorbuch (Pakar) that avoid difficulties in organization of Diabetes Mellitus.
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There are a number of targets in the form of receptors are selected for treatment of DM such as Aldose Reductase (AR), Insulin Receptor (IR) and Sirtuin-6 or Mono-ADP ribosyltransferasesirtuin-6 (SIRT6). Many more are still under exploring study to alleviate DM. AR (EC 1.1.1.21) is a monomeric, NADP-dependent oxidoreductase enzyme and a member of aldo-keto reductase multigene superfamily. Study presented that an upsurge in AR (aldose reductase) activity leads to an enlarged accumulation of intercellular sorbitol which outcomes in boosted complication in DM [7] . Another receptor called IR (Insulin receptor) which belongs to class of tyrosinekinase, a trans membrane receptor [8] .One of the most common causes DM is inactivation of insulin receptor function [9] . IR is activated by insulin, IGF-1(Insulin-like growth factor) and IGF-II (Insulin growth factor-II) and any inequity in production or response of these factors adds to a cause in DM [10] . Mono-ADP ribosyltransferase-sirtuin-6 (SIRT6) or Sirtuin-6 is a stress receptive protein deacetylase and mono-ADP ribosyl transferase enzyme programmed by the SIRT-6 gene. SIRT-6 plays role in numerous molecular pathways such as aging, including DNA repair, telomere maintenance, glycolysis and inflammation. Sirtuin-6 is a possible therapeutic target for DM [11] . 
Materials AND Methods
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Octacosanol (Table 1) were selected for docking calculation. All reported compounds with pubchem CID no, molecular formula, molecular weight, Conical smile (Table 2 ) Lipinski filter server was used to find drug likeness of selected bioactive compounds (Table  3) . The anti-diabetic compounds that showed good drug likeness properties were further used for computational screening using FAF Drug server 3 (Table 4 ). Total selected compounds as ligand were used for docking calculation with AR, IR, SIRT-6 receptors and docking was performed by YASARA tool. Out of 43 compounds, mainly 6 compounds (Gossypetin, Herbacetin, Kaempferol, Leucodelphinidin, Leucoperalgonidin, Sorbifolin) were observed as best compounds on the basis of Energy (Table 5 ) Docking results obtained for each ligand with the receptor were analyzed on the basis of docking energy (Kcal/mol) and interaction of each ligand with the functional residues of AR (PDB ID:1USO), IR (PDB ID: 1IR3), SIRT-6 (PDB ID:3K35) (Figure 1 ) with Herbacetin and Sorbifolin respectively (Figure 2 and Figure 3) . Out of six lignads Herbacetin and Sorbifolin were found best suitable ligands. In docking calculation of AR receptor and 6 ligands Trp20, Tyr48, His110, Trp111 are the most prominent binding residues (Table 6 ) and In case of IR, Leu1002, Met1079, Asp1150 are the most prominent binding residues with 6 ligands (Table 7) and In SIRT-6 Phe62, Gln111, Ile217, Asn112 are found to be the most prominent binding sites ( benghalens is has been appraised in numerous animal models by inducing diabetes using alloxan and streptozotocin. It was established that aqueous extract of bark exhibited a strong in vitro inhibitory activity against α-amylase and α-glucosidase enzymes. The ethanol extract of their leaves successfully reduced the blood glucose, triglycerides and cholesterol levels in alloxan-induced diabetic rats [19] [20] [21] [22] . In the traditional systems of medicine, F. racemosa is found all over India, Northern Australia and other parts of Asia. In this plant (leaves, fruits, bark, latex, and sap of the root) are used for treatment of diabetes. Mainly bark is used for skin diseases, ulcers, diabetes, piles, dysentery, asthma, gonorrhea, leucorrhea and urinary disease. The methanol extract of bark also presented an anti-diabetic effect in Streptozotocin and alloxaninduced diabetic rats 
Conclusion:
AR,IR,SIRT-6 used as prominent target proteins to study the interaction of selected anti-diabetic compounds isolated from various medicinal plants through the in-silico screening. A total of 6 anti diabetic compounds were selected out of 43 compounds isolated from five medicinal plants. Based on parameters like good oral bioavailability, Non-toxicity and Drug likeness Adsorption and Distribution, Metabolism, Excretion, Toxicity showing strong binding affinity with prominent binding site residues, only six compounds was selected as the best possible ligands which can be used for treatment of Type 2 Diabetes Mellitus. Leucoperalgonidin and Kaempferol were showing best docking with AR, mainly found in F. benghalensis. and F. racemosa, respectively.
